Climb Bio (CLYM) Retained Earnings (2020 - 2026)

Climb Bio (CLYM) has 6 years of Retained Earnings data on file, last reported at $157000.0 in Q1 2026.

• Quarterly Retained Earnings fell 45.1% year-over-year to $157000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $157000.0 (down 45.1% YoY) and the FY2025 annual result came in at -$289.7 million, down 1259782.61% from the prior year.
• Retained Earnings grew to $157000.0 in Q1 2026, from -$289.7 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $469000.0 in Q3 2025 to a low of -$289.7 million in Q4 2025.
• A 5-year average of -$67.5 million and a median of -$358000.0 in 2022 frame the typical range for Retained Earnings.
• Annual changes were most pronounced in 2024 — Retained Earnings plunged 2013172.73% — and 2025, when it soared 100.21%.
• Tracing CLYM's Retained Earnings over 5 years: stood at -$358000.0 in 2022, then sank by 43469.55% to -$156.0 million in 2023, then soared by 100.01% to $23000.0 in 2024, then slumped by 1259782.61% to -$289.7 million in 2025, then jumped by 100.05% to $157000.0 in 2026.
• The last three Retained Earnings figures came in at $157000.0 (Q1 2026), -$289.7 million (Q4 2025), and $469000.0 (Q3 2025), per Business Quant data.